Callahan J W
Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, ON, Canada.
Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103. doi: 10.1016/s0925-4439(99)00075-7.
GM1 gangliosidosis and Morquio B disease are distinct disorders both clinically and biochemically yet they arise from the same beta-galactosidase enzyme deficiency. On the other hand, galactosialidosis and sialidosis share common clinical and biochemical features, yet they arise from two separate enzyme deficiencies, namely, protective protein/cathepsin A and neuraminidase, respectively. However distinct, in practice these disorders overlap both clinically and biochemically so that easy discrimination between them is sometimes difficult. The principle reason for this may be found in the fact that these three enzymes form a unique complex in lysosomes that is required for their stability and posttranslational processing. In this review, I focus mainly on the primary and secondary beta-galactosidase deficiency states and offer some hypotheses to account for differences between GM1 gangliosidosis and Morquio B disease.
GM1神经节苷脂贮积症和莫尔基奥B病在临床和生化方面都是不同的疾病,但它们都源于相同的β-半乳糖苷酶缺乏。另一方面,半乳糖唾液酸贮积症和唾液酸贮积症具有共同的临床和生化特征,但它们分别源于两种不同的酶缺乏,即保护蛋白/组织蛋白酶A和神经氨酸酶。然而,尽管这些疾病各不相同,但在实际中它们在临床和生化方面都存在重叠,因此有时很难将它们轻易区分开来。造成这种情况的主要原因可能是这三种酶在溶酶体中形成了一种独特的复合物,而这种复合物是它们稳定性和翻译后加工所必需的。在这篇综述中,我主要关注原发性和继发性β-半乳糖苷酶缺乏状态,并提出一些假说来解释GM1神经节苷脂贮积症和莫尔基奥B病之间的差异。